SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-016159
Filing Date
2022-06-03
Accepted
2022-06-03 16:06:42
Documents
13
Period of Report
2022-06-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K tvst-20220602.htm   iXBRL 8-K 32450
  Complete submission text file 0001628280-22-016159.txt   202437

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvst-20220602.xsd EX-101.SCH 2604
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tvst-20220602_def.xml EX-101.DEF 14967
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvst-20220602_lab.xml EX-101.LAB 28667
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvst-20220602_pre.xml EX-101.PRE 15972
7 EXTRACTED XBRL INSTANCE DOCUMENT tvst-20220602_htm.xml XML 11594
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

IRS No.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40791 | Film No.: 22994380
SIC: 2834 Pharmaceutical Preparations